|
KMID : 0607520070150010014
|
|
Korean Journal of Psychosomatic Medicine
2007 Volume.15 No. 1 p.14 ~ p.21
|
|
|
Premenstrual Dysphoric Disorder :A Clinical Review
|
|
Hwang Gul
|
|
|
Abstract
|
|
|
|
Premenstural dysphoric disorder(PMDD) imposing 4-5% of women is possibly caused by an enhanced responsiveness to the changes of sex steroid hormones and the decrease of serotonin, melatonin and GABA. The common clinical features between PMDD and depression, seasonal affective disorder, panic disorder and anorexia nervosa suggest a relatedness between PMDD and each of them. The diagnostic criteria of DSM-IV-Tr for PMDD requires psychological symptoms, that commonly include irritability, anger, depression, mood swing, affect lability, tension, anxiety, fatigue and food craving. As of today, the best pharmacological treatment for PMDD is the selective serotonin reuptake inhibiter, and leuprolide, danazol, estradiol, spironolactone and bromocriptine are possible alternatives. Nonpharmacological treatments for patients with mild to moderate symptom severity are diet, exercise, light therapy, psychotherapy and keeping a diary.
|
|
|
KEYWORD
|
|
|
Premenstrual dysphoric disorder, Premenstrual syndrome
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|